{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T05:26:01Z","timestamp":1738992361742,"version":"3.37.0"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1095,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1002\/hep.25669","type":"journal-article","created":{"date-parts":[[2012,2,28]],"date-time":"2012-02-28T05:16:17Z","timestamp":1330406177000},"page":"1182","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Antiannexin V antibodies: An underestimated source of noncirrhotic portal vein thrombosis?"],"prefix":"10.1097","volume":"56","author":[{"given":"Jessy","family":"Cattelan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyne","family":"Racadot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Di Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Thevenot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-43-20250207","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/hep.23259","article-title":"Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter followup study.","volume":"51","author":"Plessier","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R2-43-20250207","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.autrev.2011.04.011","article-title":"New autoantigens in the antiphospholipid syndrome.","volume":"10","author":"Alessandri","year":"2011","journal-title":"Autoimmun Rev"},{"key":"R3-43-20250207","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4137\/CMAMD.S4503","article-title":"Antiannexin v antibodies: association with vascular involvement and disease outcome in patients with systemic sclerosis.","volume":"3","author":"Habeeb","year":"2010","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"key":"R4-43-20250207","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/ard.55.12.895","article-title":"Annexin V autoantibodies in rheumatoid arthritis.","volume":"55","author":"RodriguezGarcia","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"R5-43-20250207","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.autrev.2004.07.006","article-title":"Antiannexin V antibodies: are they prothrombotic?","volume":"4","author":"Esposito","year":"2005","journal-title":"Autoimmun Rev"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.25669","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201209000-00043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T16:51:47Z","timestamp":1738947107000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201209000-00043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.25669","relation":{},"ISSN":["0270-9139"],"issn-type":[{"type":"print","value":"0270-9139"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}